Jingyu Cai

Jingyu Cai is a Partner with PwC Strategy& China, focusing on pharmaceutical and life science sector. He has more than 16 years of consulting experience, specializing in regulatory environment interpretation, strategy development and execution, business model transformation, and operation optimization for pharmaceutical and life science clients. He also led many global and domestic pharma M&A cases.

His project experiences include:

• Tracked and analyzed the US FDA’s drug administration practice in a systematic way, then provided practical recommendations for China NMPA’s reference and management decision
• Facilitated pharmaceutical companies, both MNCs and domestic players, in corporate strategy development and business model innovation, reached internal alignment through workshops on the implementation plan
• Supported multinational pharmaceutical companies in market entry strategy, operating model development, and local business partner selection
• Provided organization transformation support following strategy development, and enhanced agility facing the fast-changing China healthcare market
• Facilitated pharmaCo to evaluate potentials in broad market and retail sector, then tailor made operating model and processes for multi-channel access
• Assessed a pharmaCo’s sales model effectiveness in core and broad markets, specified physician needs, then improved marketing & sales strategy
• Proposed new distributor management model for a medical device manufacturer, in response to the volume-based procurement and two-invoice policies
• Facilitated alignment between a leading TCM company’s supply chain and commercial in terms of strategy, operation model, process and KPI
• Explored collaboration between innovative drug companies and commercial insurance in oncology, rare disease, and chronic disease
• Led target screening, commercial due diligence, deal execution PMO, and post-deal integration projects in pharmaceutical and medical device sectors
• Led target screening, for investment companies and pharmaceutical companies to realize their business expansion objectives
• Coordinated legal entity restructuring projects with systematic assessment from operation, tax, legal and regulatory perspectives
• Provided IT strategic plan with implementation road map for pharmaceutical companies in commercial, manufacturing & quality control, and R&D

Education:

• Master’s Degree in Strategic Marketing, Cranfield University
• Bachelor’s Degree in Environmental Science and Engineering, Fudan University